NEUROCRINE BIOSCIENCES INC (NBIX) Forecast, Price Target & Analyst Ratings

NASDAQ:NBIX • US64125C1099

Current stock price

128.89 USD
-2.75 (-2.09%)
At close:
128.89 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEUROCRINE BIOSCIENCES INC (NBIX).

Forecast Snapshot

Consensus Price Target

Price Target
$179.79
+ 39.49% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$1.22
Revenue Estimate
790.13M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
84.44%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$179.79
Upside
+ 39.49%
From current price of $128.89 to mean target of $179.79, Based on 36 analyst forecasts
Low
$141.40
Median
$178.50
High
$214.20

Price Target Revisions

1 Month
0.10%
3 Months
-1.13%

Price Target Summary

36 Wall Street analysts provided a forecast for the next 12 months for NBIX. The average price target is 179.79 USD. This implies a price increase of 39.49% is expected in the next year compared to the current price of 128.89.
The average price target has been revised downward by 1.13% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NBIX Current Analyst RatingNBIX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

NBIX Historical Analyst RatingsNBIX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
84.44%
NBIX was analyzed by 36 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NBIX.
In the previous month the buy percentage consensus was at a similar level.
NBIX was analyzed by 36 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-10Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2026-04-07WedbushMaintains Outperform -> Outperform
2026-04-07Canaccord GenuityMaintains Buy -> Buy
2026-04-07CitigroupMaintains Buy -> Buy
2026-04-07HC Wainwright & Co.Maintains Buy -> Buy
2026-04-06NeedhamReiterate Buy -> Buy
2026-03-12JP MorganMaintains Overweight -> Overweight
2026-02-24Wolfe ResearchInitiate Outperform
2026-02-17Truist SecuritiesMaintains Buy -> Buy
2026-02-17JP MorganMaintains Overweight -> Overweight
2026-02-13Wells FargoMaintains Overweight -> Overweight
2026-02-12BMO CapitalMaintains Market Perform -> Market Perform
2026-02-12NeedhamMaintains Buy -> Buy
2026-02-12RBC CapitalMaintains Outperform -> Outperform
2026-02-12WedbushMaintains Outperform -> Outperform
2026-02-12CitigroupMaintains Buy -> Buy
2026-02-12HC Wainwright & Co.Maintains Buy -> Buy
2026-01-23UBSMaintains Buy -> Buy
2026-01-12JP MorganMaintains Overweight -> Overweight
2026-01-08Truist SecuritiesMaintains Buy -> Buy
2026-01-08Morgan StanleyDowngrade Overweight -> Equal-Weight
2025-12-17HC Wainwright & Co.Maintains Buy -> Buy
2025-12-12MizuhoMaintains Neutral -> Neutral
2025-12-11StifelMaintains Buy -> Buy
2025-12-08RBC CapitalMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$1.22
Revenue Estimate
790.13M
Revenue Q2Q
37.99%
EPS Q2Q
1,431.05%
Number of Analysts
27

Next Earnings Revisions

Revenue (1 Month)
-0.04%
Revenue (3 Months)
-0.50%
EPS (1 Month)
2.00%
EPS (3 Months)
-17.29%

Next Earnings Summary

NBIX is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 1.22 USD and the consensus revenue estimate is 790.13M USD.
The next earnings revenue estimate has been revised downward by 0.5% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
NBIX revenue by date.NBIX revenue by date.
1.887B
26.76%		2.355B
24.81%		2.861B
21.45%		3.514B
22.85%		3.878B
10.36%		4.286B
10.52%		4.37B
1.96%		4.7B
7.55%		5.346B
13.74%		5.644B
5.57%		5.969B
5.76%
EBITDA
YoY % growth
NBIX ebitda by date.NBIX ebitda by date.
416.1M
56.25%		610.1M
46.62%		666.6M
9.26%		738.07M
10.72%		942.73M
27.73%		1.236B
31.11%		1.377B
11.41%		1.58B
14.74%		2.364B
49.62%		3.137B
32.70%		3.637B
15.94%
EBIT
YoY % growth
NBIX ebit by date.NBIX ebit by date.
394.8M
57.48%		583M
47.67%		636.5M
9.18%		808.43M
27.01%		1.052B
30.13%		1.307B
24.24%		1.406B
7.57%		1.7B
20.91%		2.599B
52.88%		2.858B
9.97%		3.357B
17.46%
Operating Margin
NBIX operating margin by date.NBIX operating margin by date.
20.92%24.75%22.25%23.01%27.13%30.49%32.17%36.17%48.62%50.64%56.24%
EPS
YoY % growth
NBIX eps by date.NBIX eps by date.
2.42
58.17%		3.29
35.95%		4.66
41.64%		6.11
31.12%		8.29
35.71%		10.55
27.22%		13.38
26.83%		15.29
14.28%		16.18
5.84%		17.50
8.11%		19.63
12.21%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		1.22
1,431.05%		1.48
39.81%		1.76
-13.64%		1.69
14.18%		1.98
61.56%		2.33
56.92%		2.49
41.41%		2.53
49.69%
Revenue
Q2Q % growth		790.13M
37.99%		866.72M
26.07%		922.25M
16.02%		948.32M
17.73%		977.93M
23.77%		1.03B
18.84%		1.067B
15.70%		1.076B
13.46%
EBITDA
Q2Q % growth		164.99M
427.12%		188.68M
17.56%		198.89M
-24.06%		193.77M
-24.90%		N/AN/AN/AN/A
EBIT
Q2Q % growth		146.13M
516.58%		197.2M
35.44%		228.37M
-4.57%		231.69M
1.66%		206.89M
41.58%		262.65M
33.19%		292.55M
28.10%		295.36M
27.48%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NBIX Yearly Revenue VS EstimatesNBIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B 5B
NBIX Yearly EPS VS EstimatesNBIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 10 15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
31.30%
EPS Next 5 Year
26.83%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
13.87%
Revenue Next 5 Year
10.12%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
22.66%
EBIT Next 5 Year
18.73%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NEUROCRINE BIOSCIENCES INC / NBIX Forecast FAQ

Can you provide the average price target for NEUROCRINE BIOSCIENCES INC stock?

36 analysts have analysed NBIX and the average price target is 179.79 USD. This implies a price increase of 39.49% is expected in the next year compared to the current price of 128.89.

What is the next earnings date for NBIX stock?

NEUROCRINE BIOSCIENCES INC (NBIX) will report earnings on 2026-05-04.

What are the consensus estimates for NEUROCRINE BIOSCIENCES INC (NBIX) next earnings?

The consensus EPS estimate for the next earnings of NEUROCRINE BIOSCIENCES INC (NBIX) is 1.22 USD and the consensus revenue estimate is 790.13M USD.

Can you provide the consensus rating for NEUROCRINE BIOSCIENCES INC stock?

The consensus rating for NEUROCRINE BIOSCIENCES INC (NBIX) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.